Form 4: Bluebird Bio CEO Andrew Obenshain Sells Shares to Cover Tax Obligations
SEC Form 4
Andrew Obenshain, President and CEO of bluebird bio, Inc., sold 86 shares of common stock on February 3, 2025, to cover tax withholding obligations.
Summary
- Andrew Obenshain, the President and CEO of bluebird bio, Inc., executed a sale of company stock on February 3, 2025.
- A total of 86 shares of common stock were sold at an average weighted price of $7.3925, with prices ranging from $7.27 to $7.55.
- The sale was conducted to cover tax withholding obligations related to the vesting of Restricted Stock Units.
- Following the transaction, Obenshain directly owns 18,485 shares of bluebird bio stock.
Sentiment
Score: 5
Explanation: The document reports a routine transaction (stock sale for tax obligations). It doesn't contain information that would significantly sway investor sentiment positively or negatively.
Industry Context
Sales of shares to cover tax obligations are a routine part of equity compensation and are not necessarily indicative of the executive's view of the company's future prospects.
Key Dates
| Date | Description |
|---|---|
| 2024-09-23 | Date of execution for Power of Attorney. |
| 2025-02-03 | Date of stock sale transaction. |
| 2025-02-05 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.